ARF6 and neoplasm: Doxycycline-induced knockdown of ARF6 significantly reduced tumor growth in vivo (Fig. 5b), demonstrating that ARF6 has a role in tumor progression that is independent of the ARF6-mediated adaptive immune suppression we observed in immunocompetent mice12.